Ahmedabad-based Zydus Cadila has made a foray into the US generic formulation segment by setting up a subsidiary Zydus Pharmaceuticals USA, Inc.
The new company would supply finished dosage formulations to the US generic market, Zydus Cadila said in a release in Mumbai on Thursday.
The US subsidiary would be headed by Joseph Renner, who was earlier chief operating officer of Sandoz USA, as the chief executive officer, it added.
Zydus Cadila chairman and managing director Pankaj Patel said, "Significant effort and progress has already been made to realise our plans to grow revenues from overseas regulated markets and these efforts have been accelerated with setting up of the US subsidiary."
The company has filed 12 active pharmaceutical ingredient Drug Master Files and two finished dosage abbreviated new drug applications with the US Food and Drug Administration, he added.
